Financhill
Back

Xylem, Inc. Vs. Apellis Pharmaceuticals, Inc. Industry Stock Comparison

Buy
62

XYL
Xylem, Inc.

Last Price:
$139.42
Seasonality Move:
1.18%
Sell
36

APLS
Apellis Pharmaceuticals, Inc.

Last Price:
$26.47
Seasonality Move:
2.66%
Buy
62
Xylem, Inc. (XYL) is a Buy

Is Xylem, Inc. a Buy, Sell or Hold?

  • The current Xylem, Inc. [XYL] share price is $141.33. The Score for XYL is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • XYL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Apellis Pharmaceuticals, Inc. (APLS) is a Sell

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals, Inc. [APLS] share price is $23.94. The Score for APLS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XYL Stock Price Chart

What is Xylem, Inc.'s stock price today?

  • The Xylem, Inc. share price today is $141.33
    The current trend is relatively stagnant and XYL is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

  • The Apellis Pharmaceuticals, Inc. share price today is $23.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

XYL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 56.87 Buy
Chaikin Money Flow: 854958 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (137.18 - 139.84) Buy
Bollinger Bands (100): (138.67 - 147.41) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.59 Buy
Relative Strength Index (14 RSI): 48.27 Sell
Chaikin Money Flow: -1351238 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.59 - 25.53) Sell
Bollinger Bands (100): (21.4 - 27.16) Sell

XYL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 138.39 Buy
20-day SMA: 138.16 Buy
50-day SMA: 142.44 Sell
200-day SMA: 134.27 Buy
8-day EMA: 138.69 Buy
20-day EMA: 138.86 Buy
50-day EMA: 140.67 Buy
200-day EMA: 136.93 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.91 Sell
20-day SMA: 24.75 Sell
50-day SMA: 23.01 Buy
200-day SMA: 21.91 Buy
8-day EMA: 24.76 Sell
20-day EMA: 24.34 Sell
50-day EMA: 23.66 Buy
200-day EMA: 24.33 Sell

Xylem, Inc. Earnings Growth & XYL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.61 per share.

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.44 per share, and an increase next year of $0.91 per share.

Xylem, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):